Generic Name: INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215
Dosage Form: suspension for intramuscular injection
Drug Class: Viral vaccines
Generic Name: INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215
Dosage Form: suspension for intramuscular injection
Drug Class: Viral vaccines
For intramuscular use only
The dose and schedule for Fluzone Quadrivalent are presented in Table 1.
Prior to vaccination, always refer to the current Advisory Committee on Immunization Practices annual recommendations on prevention and control of influenza vaccines.
Age | Vaccination Status | Dose | Schedule |
---|---|---|---|
"-" Indicates information is not applicable | |||
|
|||
6 months through 35 months | Not previously vaccinated with influenza vaccine or unknown vaccination history | Two doses, either 0.25 mL or 0.5 mL* | Administer at least 4 weeks apart |
Previously vaccinated with influenza vaccine | One or two doses†, either 0.25 mL or 0.5 mL* | If two doses, administer at least 4 weeks apart | |
36 months through 8 years | Not previously vaccinated with influenza vaccine or unknown vaccination history | Two 0.5 mL doses | Administer at least 4 weeks apart |
Previously vaccinated with influenza vaccine | One or two 0.5 mL doses† | If two doses, administer at least 4 weeks apart | |
9 years and older | - | One 0.5 mL dose | - |
Parenteral drug products should be inspected visually for particulate matter and/or discoloration prior to administration, whenever solution and container permit. If any of these defects or conditions exist, Fluzone Quadrivalent should not be administered.
Before administering a dose of vaccine, shake the prefilled syringe or vial. Withdraw one dose of vaccine from the single-dose vial using a sterile needle and syringe. Discard unused portion. Use a separate sterile needle and syringe for each dose withdrawn from the multi-dose vial. A maximum of ten doses can be withdrawn from the multi-dose vial.
The preferred sites for intramuscular injection are the anterolateral aspect of the thigh in infants 6 months through 11 months of age, the anterolateral aspect of the thigh (or the deltoid muscle if muscle mass is adequate) in persons 12 months through 35 months of age, or the deltoid muscle in persons ≥36 months of age. The vaccine should not be injected into the gluteal area or areas where there may be a major nerve trunk.
Do not administer this product intravenously, intradermally, or subcutaneously.
Fluzone Quadrivalent should not be combined through reconstitution or mixed with any other vaccine.